Drug news
FDA issues warnings on Avastin
The FDA has issued new warnings concerning Avastin (bevacizumab) from Genentech/Roche, in relation to ovarian failure, osteo-necrosis of the jaw and venous thromboembolism ,including bleeding. These warnings have been added to the US label. The FDA has also indicated thea it is likely to remove the breast cancer indication of the drug.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins